The interplay of prostatic inflammation with NF‐κB and GDF‐15 expression in early prostate cancer development is unclear from our study results, although our findings suggest GDF‐15 may repress chronic inflammation in the benign prostate. Here, NFKB1 is linked to inflammatory response.